Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
J Anim Sci ; 88(8): 2751-66, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20407070

ABSTRACT

Pigs (n = 240) were allotted in a 5 x 2 factorial arrangement with 5 levels of distillers dried grains with solubles (DDGS): 0, 15, 30, 45, and 60%, and 2 ractopamine (RAC) levels: 0 and 5 mg/kg. Four pigs per pen (2 barrows, 2 gilts) closest to pen mean BW were used for meat quality evaluation. Loins (n = 119) were evaluated for objective color; moisture and fat; subjective color, marbling, and firmness; and drip loss. Bellies (n = 119) were evaluated for weight, length, width, thickness, objective fat color, and firmness. Cured bellies were evaluated for pump yield, cook loss, and sliced bacon cook loss. Loin thiobarbituric acid reactive substances (TBARS) were evaluated on enhanced (salt and phosphate) boneless chops held in modified atmosphere (80% O(2)/20% CO(2)) packages for 0, 7, 14, and 21 d. Bacon TBARS were evaluated on sliced bacon held in vacuum packages for 0, 28, 56, and 84 d. Fat samples were collected from each jowl and belly and evaluated for fatty acid profile and iodine value (IV). Increasing DDGS decreased subjective marbling (P = 0.0134) and firmness (P = 0.0235), and increased drip loss (P = 0.0046). Distillers dried grains with solubles did not affect loin pH, subjective or objective color, percent moisture, or percent fat (P > 0.05). The RAC decreased subjective color (P = 0.0239), marbling (P = 0.0445), and a* (P = 0.0355). Increasing DDGS decreased belly weight (P = 0.0155), length (P = 0.0008), thickness (P = 0.0019), and firmness (P = 0.0054); decreased belly fat L* (P = 0.0818); and increased belly cook loss (P = 0.0890). Ractopamine did not affect any belly measurements, and there were no DDGS x RAC interactions (P > 0.05). Distillers dried grains with solubles did not affect loin TBARS at 0, 7, or 14 d. At 21 d, loin TBARS from 30, 45, and 60% DDGS groups were increased compared with 0 and 15% groups (P < 0.05). Ractopamine did not affect (P > 0.05) loin TBARS, and there were no (P > 0.05) DDGS x RAC interactions. Distillers dried grains with solubles and RAC did not affect bacon TBARS (P > 0.05). Increasing DDGS increased belly (P = 0.0207) and jowl (P < 0.0001) IV, and decreased MUFA:PUFA in belly (P < 0.0001) and jowl (P < 0.0001) fat. Ratio of SFA:unsaturated fatty acids decreased in jowl (P = 0.0002) and belly fat (P = 0.2815). Ractopamine did not affect fatty acid profiles or IV, and there were no DDGS x RAC interactions (P > 0.05). Results indicate that increased DDGS have minimal effects on loin quality, but decrease belly quality, bacon processing characteristics, and fat stability. Ractopamine does not negatively affect these characteristics and does not interact with DDGS.


Subject(s)
Animal Feed , Food Additives/pharmacology , Growth Substances/pharmacology , Meat/standards , Phenethylamines/pharmacology , Animals , Cattle , Edible Grain , Fatty Acids/analysis , Female , Food Preservation , Male , Meat/analysis , Swine
2.
J Anim Sci ; 83(12): 2886-93, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16282628

ABSTRACT

One hundred eighty barrows were evaluated to determine the effects of ractopamine hydrochloride (RAC) on lean carcass yields and pork quality. The pens were blocked by weight (six pens per block) with starting block weights of 69.0, 70.7, 73.8, 76.6, 78.4, and 84.3 kg. Pens within a block were assigned randomly to one of three RAC treatments so each treatment in a block was replicated twice. Treatments (as-fed basis) included control diet, 10 ppm of RAC added (R10), and 20 ppm of RAC added (R20) and ranged from 25 to 41 d depending on block. Pigs were slaughtered by blocks when block average live weights were 109 kg. Gain and feed efficiency were improved (P < 0.05) with increasing dietary concentrations of RAC, but feed intake did not differ (P > 0.05). Dressing percentage was higher (P < 0.05) for RAC-treated pigs. Subjective color, firmness, marbling scores, and Minolta L* reflection of the LM were not different (P > 0.05) among treatments. Carcass weights were heavier (P < 0.05) for pigs treated with RAC compared with control pigs and were higher for R20 than for R10. The RAC-fed pigs had greater (P < 0.05) yields (actual and percentage of HCW) of the following Institutional Meat Purchase Specification (IMPS) cuts than control pigs: trimmed, boneless ham (IMPS-402C and IMPS-402G), loin (IMPS-414), sirloin, and Boston butt (IMPS-406A). Pigs treated with RAC had a greater (P < 0.05) percentage of fat-free lean trimmings (IMPS-418) than did control pigs. Pigs treated with the R20 concentration had increased (P < 0.05) water-holding capacity compared with control pigs. Purge loss decreased linearly (P < 0.05) with increasing RAC compared with control for 14-d aged, non-enhanced loins. Warner-Bratzler shear (WBS) force values measured for nonenhanced chops were greater for RAC-treated pigs than for control pigs with a low dose response (P = 0.001). Enhanced chop (salt and phosphate injection) WBS values did not differ (P > 0.05) among dietary treatments. Trained sensory evaluation panel results for tenderness decreased in a low-dose plateau response fashion for nonenhanced chops (P = 0.004). Tenderness of enhanced chops decreased linearly (P = 0.04) with increasing RAC concentrations. No differences (P > 0.05) were found in juiciness or flavor of enhanced or nonenhanced chops. Feeding RAC to late-finishing swine resulted in faster growing, more efficient animals with increased boneless subprimal yields, and it had little effect on pork juiciness and flavor.


Subject(s)
Adrenergic beta-Agonists/pharmacology , Body Composition/drug effects , Meat/standards , Phenethylamines/pharmacology , Swine/growth & development , Animals , Growth Substances/pharmacology
3.
J Vasc Interv Radiol ; 5(3): 433-8, 1994.
Article in English | MEDLINE | ID: mdl-8054741

ABSTRACT

PURPOSE: This study was undertaken to determine the prevalence of rigors associated with the use of urokinase (UK) and to assay for the presence of an endotoxin in the UK solution. PATIENTS AND METHODS: Records of 75 patients who underwent 86 UK infusions between January 1988 and July 1992 were reviewed to evaluate for the development of UK-associated rigors. A modified chromogenic limulus amebocyte lysate (LAL) test was performed to determine the presence of endotoxin in four samples of UK from lots associated with rigors, one sample of UK not associated with rigors, sterile water, nonionic contrast medium, and ionic contrast medium. RESULTS: Between January 1, 1988, and July 10, 1990, 43 patients underwent 46 UK treatments (group 1) with no documented rigors (0% prevalence). In 45 of these 46 treatments, a standard, non-pulse-spray bolus of 75,000-500,000 IU of UK (mean dose, 182,222 IU) was used. Between July 11, 1990, and July 6, 1992, 38 patients underwent 40 UK treatments (group 2). In 33 of these 40 treatments, a standard bolus was given. Five patients received a pulse-spray bolus. The mean bolus was 213,768 IU (range, 100,000-500,000 IU). Eleven group 2 patients developed rigors (28% prevalence; P = .0005 vs group 1). The chromogenic LAL tests demonstrated no endotoxin in sterile water, nonionic contrast media, or ionic contrast media. Endotoxin was detected in small concentrations in the four samples of UK associated with rigors and in the UK sample not associated with rigors. CONCLUSION: The increase in the prevalence of rigors associated with the use of UK does not appear to be related to an endotoxin in UK, since the concentration of endotoxin detected is well below the threshold pyrogenic dose in humans.


Subject(s)
Endotoxins/analysis , Shivering , Thrombolytic Therapy , Urokinase-Type Plasminogen Activator/adverse effects , Contrast Media/analysis , Drug Contamination , Female , Humans , Limulus Test , Male , Middle Aged , Prevalence , Retrospective Studies , Time Factors , Urokinase-Type Plasminogen Activator/analysis , Urokinase-Type Plasminogen Activator/therapeutic use , Water/analysis
SELECTION OF CITATIONS
SEARCH DETAIL